Multicompartment models of cancer chemotherapy incorporating resistant cell populations
- 1 April 1987
- journal article
- conference paper
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 15 (2) , 145-177
- https://doi.org/10.1007/bf01062341
Abstract
The pharmacokinetics of antineoplastic drugs based on compartmental models are combined with deterministic exponential growth models of tumors containing drug-resistant and sensitive cells. Model predictions for single-drug therapy are compared with in vivodata obtained by other investigators for L1210 t-cell leukemia in mice treated with BCNU and AraC and for in vitrotreatment of L1210 with Ara-C. The model and data compare favorably in terms of rate of tumor growth and duration of drug action for both constant infusion and bolus delivery of the drugs.This publication has 27 references indexed in Scilit:
- A model for the resistance of tumor cells to cancer chemotherapeutic agentsMathematical Biosciences, 1983
- Criteria for Analyzing Interactions between Biologically Active AgentsAdvances in Cancer Research, 1981
- THE GOMPERTZ EQUATION AND THE CONSTRUCTION OF TUMOUR GROWTH CURVESCell Proliferation, 1980
- The relevance of certain concepts of cell cycle kineticsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1978
- Optimal control analysis in the chemotherapy of IgG multiple myelomaBulletin of Mathematical Biology, 1977
- Analysis and identification of stochastic compartment models in pharmacokinetics: implication for cancer chemotherapyMathematical Biosciences, 1974
- A pharmacodynamic model for cell-cycle-specific chemotherapeutic agentsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Models of ARA-C chemotherapy of L1210 leukemia in miceJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Mathematical representations of cancer chemotherapy effectsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971